Medical Devices Startups

PhorMed develops next-generation therapies targeting inflammation-driven diseases, particularly rare oncological conditions, using AI-powered targeting technology. The company serves patients with inflammatory and cancer-related diseases, focusing on improving efficacy and safety of first-line treatments.

1 investor

PhosPrint develops bioprinters designed to print bio-inks for tissue engineering applications. The company's Dual Beam I system combines printing and post-processing capabilities for cellular constructs.

1 investor

Photon etc. distributes optics and photonics technologies through a global network of specialized partners, serving researchers and industries in life science, material science, and industrial applications.

1 investor

PhotoPharmics is a clinical-stage medical device company developing non-invasive, light-based photo-neuromodulation therapies for neurodegenerative disease, with a focus on Parkinson's disease. Its investigational device Celeste delivers light through the eyes at home and is being evaluated in clinical trials targeting non-motor symptoms such as sleep, fatigue, and mood.

1 investor

Phyla produces skincare products for acne-prone skin, including a pH-balancing gel cleanser that removes excess oil without irritation. The company focuses on microbiome-conscious formulations recommended by dermatologists.

1 investor

PIA Medical provides cardiovascular imaging analysis software and services for medical professionals. The company focuses on magnetic resonance imaging and advanced cardiac image analysis to support clinicians in cardiovascular diagnosis and treatment.

1 investor

Picard Medical is the parent company of SynCardia Systems, which develops and commercializes the SynCardia Total Artificial Heart (STAH), the only FDA and Health Canada-approved total artificial heart for patients awaiting donor hearts. The company also develops the Emperor System, a fully implantable artificial heart designed to eliminate external drivers.

1 investor

Picodya develops microfluidic diagnostic technology designed to increase access to diagnostic testing worldwide. The company applies its pico technology platform to enable faster, more efficient medical diagnostics for global populations.

1 investor

Picterus develops a smartphone-based application for screening newborns for jaundice using a color calibration card, serving healthcare professionals and parents across hospitals, clinics, and home care settings. The solution combines a certified medical app with hardware calibration cards to enable fast, non-invasive bilirubin screening with results aligned to clinical guidelines.

1 investor

PinCell is a pre-clinical stage biotech company developing first-in-class anti-inflammatory therapies that target novel pathological pathways for dermatological diseases, with a focus on orphan skin disorders with high unmet medical need.

1 investor

PIUR IMAGING develops vendor-agnostic AI software that adds 3D imaging and other capabilities to existing ultrasound systems, aimed at clinicians and healthcare systems without requiring them to replace their equipment. The company operates in the medical imaging software category, with offices in the US and EU.

1 investor

Pixacare provides AI-powered wound documentation and tracking software that captures medical photography, performs automated wound measurements, and enables remote monitoring of healing for hospitals and clinics. The platform is used across multiple surgical and medical specialties to simplify clinical documentation and improve care coordination.

1 investor

Pixl.bio produces iPSC-derived hepatic stellate cells for liver disease modeling and fibrosis research. The cells are used in studies of metabolic-associated fatty liver disease (MASLD), steatohepatitis, and chronic liver injury.

1 investor

Plair develops and manufactures optical detectors for real-time environmental monitoring, using aerosol measurement and fluorescence spectroscopy to continuously analyze airborne particles such as pollen, fungi, bacteria, viruses, and air pollution. Its systems serve outdoor pollen and bioaerosol detection as well as indoor viable particle and biocontamination monitoring.

1 investor

Planet Innovation provides product design, engineering, and manufacturing services to healthcare companies developing diagnostics, life sciences, and medical devices. The firm also makes strategic investments in healthtech companies and emphasizes a market-driven approach to product development and commercialization.

1 investor

PLAS-FREE develops medical devices that remove specific substances from blood products to treat life-threatening conditions such as hemorrhage and hepatic encephalopathy. The company targets hospitals and blood transfusion centers with devices designed for emergency and critical care settings.

1 investor

Plasana Medical develops a cold plasma-based medical device for wound healing that accelerates healing time and reduces infection risk. The company targets healthcare providers and patients in France and Europe, with plans to market the device following CE certification.

1 investor

PlasmaBiotics develops endoscope reprocessing equipment including pre-cleaning, drying, and active storage systems for medical facilities. The company's products—AquaTYPHOON, PlasmaTYPHOON, and PlasmaBAG—reduce reprocessing times and minimize bacterial contamination risks in healthcare settings.

1 investor

Plasmacure develops cold plasma medical technologies for healthcare, working with researchers, clinicians and industry partners to meet medical and regulatory standards. Its main application is advanced wound care through a device that combines cold plasma with mild electrostimulation.

1 investor

Platinum Dermatology Partners operates a network of dermatopathology laboratories that provide diagnostic services to dermatologists within its network. The company delivers histopathological analysis and diagnostic insights to support accurate patient diagnoses and treatment planning across the United States.

1 investor

PlatoScience develops wireless, at-home transcranial direct current stimulation (tDCS) headsets and remote-management software for clinicians, researchers, and patients. Its products include PlatoCare, approved for treating depression in the EU and UK, and PlatoWork for general tDCS use in markets such as the US, Turkey, and Malaysia.

1 investor

Playhouse MD designs playful medical devices and healthcare products for children, reimagining clinical tools through characters and storytelling to reduce anxiety during medical visits. The company serves parents and pediatricians seeking to make children's healthcare more engaging and less intimidating.

1 investor

A regenerative medicine company developing platform technologies and products for the bio and medical regeneration industry, applying research in skin and tissue regeneration to improve quality of life. Its work is led by plastic surgery clinical and research faculty.

1 investor

Pleioflow develops minimally invasive flow assist devices designed to prevent renal failure in cardiac surgery patients and those experiencing acute kidney injury. The company focuses on medical devices for cardiac assist and renal protection applications.

1 investor